Stargardt disease is an inherited form of juvenile macular degeneration, most commonly linked to mutations in the ABCA4 gene, that causes progressive loss of central vision due to damage to the macula. There is currently no treatment that corrects the underlying genetic cause. For patients who have been told there is no established treatment for their vision loss, some explore stem cell therapy as an additional option to discuss with a specialist, alongside genetic counselling and low-vision support.
Stargardt disease has no approved treatment that reverses vision loss, and management is largely limited to genetic counselling, UV protection, nutritional guidance, and low-vision aids. Patients who want to understand whether newer regenerative approaches may be relevant to their case sometimes seek a specialist evaluation combining advanced retinal imaging with an opinion on stem cell therapy.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for every patient's individual case.
Dr. Pallavee brings over two decades of clinical ophthalmology experience, supporting the eye-specific evaluation and treatment planning for patients undergoing stem cell therapy for optic nerve and retinal conditions at Stem Cell Cure India.
Mesenchymal Stem Cells (MSCs) are being studied for their potential to support retinal pigment epithelium and photoreceptor health, and for anti-inflammatory effects, in some inherited retinal conditions. It is important to understand that stem cell therapy does not correct the underlying ABCA4 gene mutation, and is not established as a treatment that restores vision already lost. This approach is explored as a complement to — not a replacement for — genetic counselling, low-vision rehabilitation, and monitoring by a retina specialist.
Suitability depends on the stage of disease and remaining visual function. Before travelling, our team reviews:
No. Stargardt disease is a genetic condition, and stem cell therapy does not correct the underlying gene mutation. It is explored as an option that may help support retinal health, alongside genetic counselling and low-vision care — it is not a cure.
Gene therapy approaches for Stargardt disease are an active area of research but remain largely investigational and are not widely available as an approved treatment. Discuss current research options with your retina specialist.
Recent OCT scan, fundus autofluorescence imaging, ERG results if available, and genetic test report if you have had one. This allows our team to give an initial opinion before you commit to travel.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up and treatment plan required.
Yes. Once an evaluation is confirmed, we provide the invitation and supporting documents needed to apply for a Medical Visa.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews). They reflect general patient experience and are not specific to this condition unless noted.
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
